Watching a single enzyme switch from a standstill to full sprint while decoding DNA inside a mammalian cell would have sounded like science fiction not long ago, yet that leap just became a measurable reality thanks to a single-molecule transcription platform that links factor binding to RNA
In this conversation, we explore why metastatic recurrence strikes nearly one in ten adolescents and young adults (AYAs) who initially present with non-metastatic cancers, how statewide data were linked to reveal patterns across tumor types, and what these findings mean for surveillance, equity,
Imagine starting each day with a steaming cup of tea, a ritual cherished by millions worldwide for its soothing aroma and perceived wellness perks. Yet, beneath this comforting habit lies a complex debate: Is tea truly a health elixir, or does it harbor hidden risks? This roundup dives into the
I'm thrilled to be speaking with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of cutting-edge cancer treatment technologies. Today, we’ll dive into the groundbreaking work on nanodots made from molybdenum
After first-line therapy fails in advanced biliary cancer, the next decision can stretch between hope for extra months and fear of heavy toxicity, a fraught balance that now places FOLFIRINOX squarely under the spotlight. Clinics see this crossroads every week: a patient who just progressed on
In operating rooms where silence often amplifies stress, a small change—a pair of headphones and a vigilant recovery plan—can shift the arc of the first hours after colorectal cancer surgery, easing the path from anesthesia to wakefulness while trimming complications that make families and